During the pandemic, the United States supported the WHO through collaborative operations. Let’s understand in detail below.
The United States government has historically supported WHO financially, through involvement in governance and diplomacy, and through collaborative operations. A new chapter in the U.S. relationship with WHO began in 2020, following the start of the COVID-19 pandemic, when the Trump administration ceased financial support and started the process to withdraw the country from membership.
The United States has traditionally been the single largest donor to WHO, but in the 2020–2021 period it was the second largest as other donors, particularly Germany, increased their contributions. The U.S. dropped to third place. The United States contributed an anticipated $581 million to the WHO in 2021 as a result of restored funding from the Biden administration, which included both assessed and voluntary contributions.
The assessed contribution for the United States has been set at the maximum permitted rate of 22%
of all assessed payments from member states for a number of years. The U.S. assessed contribution has been very consistent between FY 2014 and FY 2022, varying between $110 million and $123 million
Increased U.S. support for particular WHO initiatives, such as emergency response, may be reflected in higher levels of voluntary contributions. Other WHO initiatives supported by U.S. voluntary donations include the fight against polio, maternal, infant, and child health initiatives, food safety initiatives, and regulatory monitoring of pharmaceuticals.
The United States has long been a prominent and involved member of the World Health Assembly, sending a sizable delegation that is typically headed by a delegate from the Department of Health and Human Services and includes representatives from numerous other U.S. agencies and departments.
Government officials from the United States frequently act as liaisons at WHO regional offices and headquarters, collaborating daily with employees on technical initiatives.
The United States has collaborated with WHO both before and during epidemic responses and other global health emergencies, notably by joining multinational teams that WHO organises to look into and address outbreaks all around the world. For instance, the US collaborated with WHO and the larger global response to the 2014-onset Ebola epidemic in West Africa, and US scientists were a part of the WHO mission that visited China in February 2020 to evaluate their COVID-19 response.